CNS Pharmaceuticals

Home » CNS Pharmaceuticals

IPO

CNS Pharmaceuticals

Pharmaceutical

We are a preclinical stage pharmaceutical company organized as a Nevada corporation in July 2017 to focus on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.

Symbol

CNSP

Price Range
$4.00 - $5.00

Final Shares
2,125,000

Anticipated Date
November 8, 2019

Underwriters
THE BENCHMARK COMPANY, LLC

To view the prospectus for CNS Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253